Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
Tweet Send to a Friend
(Updated - September 1, 2026 6:33 AM EDT)
Piper Sandler analyst Dave Westenberg downgraded Myriad Genetics (NASDAQ: MYGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Dave Westenberg downgraded Myriad Genetics (NASDAQ: MYGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
